Reply
- PMID: 37217156
- DOI: 10.1016/j.cgh.2023.05.011
Reply
Comment on
-
Efficacy of Mesalamine in Irritable Bowel Syndrome.Clin Gastroenterol Hepatol. 2023 Dec;21(13):3462-3463. doi: 10.1016/j.cgh.2023.03.021. Epub 2023 Mar 29. Clin Gastroenterol Hepatol. 2023. PMID: 37001712 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources